Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTATDGJ)

DTT Name	Calcium signal-modulating cyclophilin ligand (CAML) DTT Info
Gene Name	CAMLG

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Clinical Trial Drug(s)

Preclinical Drug(s)

Discontinued Drug(s)

Download the Complete Related Drug List

2 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Alisporivir	DM83EBP	Duchenne dystrophy	8C70	Phase 3	[1]
SCY-635	DM1C9NQ	Hepatitis C virus infection	1E51.1	Phase 2	[2]
------------------------------------------------------------------------------------

1 Preclinical Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
SCY-641	DMELFBU	Ocular inflammation	9C61.24	Preclinical	[3]
------------------------------------------------------------------------------------

1 Discontinued Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
D-43787	DM0YFZ6	Allergy	4A80-4A85	Terminated	[4]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A. PLoS One. 2010 Oct 27;5(10):e13687.
2	SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro. Antimicrob Agents Chemother. 2010 Feb;54(2):660-72.
3	2011 Pipeline of SCYNEXIS.
4	Anti-inflammatory effects of a cyclosporine receptor-binding compound, D-43787. J Pharmacol Exp Ther. 2002 May;301(2):738-46.